IN8bio, Inc.

MUN:6JH Stock Report

Market Cap: €35.5m

IN8bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6JH?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,282,9169.32%
General Public4,883,10619.9%
VC/PE Firms7,527,56730.7%
Individual Insiders9,808,56840%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.6%.

Top Shareholders

Top 25 shareholders own 80.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
30.7%
Bios Equity Partners LP
7,527,567€10.9m0%no data
17.3%
Emily Fairbairn
4,231,000€6.1m22.9%no data
10.5%
Tai-Wei Ho
2,571,244€3.7m1.03%no data
10.4%
William Ho
2,541,859€3.7m0%no data
4.07%
Steelhead Capital Management, LLC
997,433€1.4m0%no data
1.53%
Voss Capital, LLC
375,570€544.8k-25.7%0.14%
1.17%
Peter Brandt
287,763€417.4k57.7%no data
0.95%
Stonegate Investment Group, LLC
232,310€337.0k-12.8%0.02%
0.69%
The Vanguard Group, Inc.
169,528€245.9k53.2%no data
0.41%
Lawrence Lamb
99,730€144.7k0.53%no data
0.4%
Sigma Planning Corporation
98,750€143.3k1.02%0.01%
0.33%
The Rock Creek Group, LP
81,568€118.3k-5.19%0.01%
0.3%
Bridgeway Capital Management, LLC
74,000€107.3k23.3%no data
0.29%
Ensign Peak Advisors Inc.
70,028€101.6k0%no data
0.23%
Alan Roemer
55,989€81.2k88.7%no data
0.21%
Geode Capital Management, LLC
52,347€75.9k489%no data
0.2%
Precept Capital Management, L.P.
50,000€72.5k0%0.57%
0.095%
BlackRock, Inc.
23,354€33.9k-17.9%no data
0.061%
Warberg Asset Management
15,000€21.8k0%0.06%
0.058%
HighTower Advisors, LLC
14,164€20.5k0%no data
0.057%
United Asset Strategies Inc.
14,000€20.3k0%no data
0.036%
UBS Asset Management
8,724€12.7k117%no data
0.032%
Luba Greenwood
7,826€11.4k7.21%no data
0.021%
Kate Rochlin
5,263€7.6k0%no data
0.021%
Patrick McCall
5,263€7.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/29 21:03
End of Day Share Price 2022/09/01 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IN8bio, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kalpit PatelB. Riley Securities, Inc.
Swayampakula RamakanthH.C. Wainwright & Co.
Soumit RoyJonesTrading Institutional Services, LLC